Expression Table for this CRE
| CNhs14498 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2 | 2868.3 |
| CNhs12060 | Skeletal Muscle Cells, donor6 | 46.1 |
| CNhs14489 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2 | 44.3 |
| CNhs12229 | pituitary gland, adult, donor10252 | 39.0 |
| CNhs13841 | iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2 | 37.6 |
| CNhs14493 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3 | 30.5 |
| CNhs14496 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3 | 25.2 |
| CNhs12045 | Smooth Muscle Cells - Coronary Artery, donor3 | 24.1 |
| CNhs11725 | argyrophil small cell carcinoma cell line:TC-YIK | 22.3 |
| CNhs12061 | Fibroblast - Cardiac, donor6 | 22.3 |
| CNhs12052 | Fibroblast - Dermal, donor4 | 21.6 |
| CNhs12663 | MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2 | 21.1 |
| CNhs12662 | MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2 | 20.0 |
| CNhs11718 | mesenchymal stem cell line:Hu5/E18 | 18.4 |
| CNhs12064 | Anulus Pulposus Cell, donor2 | 15.1 |
| CNhs12657 | MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2 | 14.7 |
| CNhs13434 | mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1 | 13.8 |
| CNhs11680 | lung, fetal, donor1 | 13.1 |
| CNhs12664 | MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2 | 12.7 |
| CNhs12953 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15) | 12.5 |
| CNhs12666 | MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2 | 11.5 |
| CNhs14490 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3 | 10.7 |
| CNhs14497 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1 | 10.6 |
| CNhs14518 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3 | 10.3 |
| CNhs12642 | Bronchial Epithelial Cell, donor7 | 10.0 |
| CNhs14495 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2 | 9.8 |
| CNhi10525_AGT | Human primary dermal fibroblasts derived from neonatal foreskin, biol_rep1 | 9.1 |
| CNhs14501 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2 | 9.0 |
| CNhs14595 | Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1 | 9.0 |
| CNhs14592 | Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1 | 9.0 |
| CNhs13845 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2 | 8.9 |
| CNhs11723 | leiomyoma cell line:15242A | 8.7 |
| CNhs12655 | MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2 | 8.6 |
| CNhs11722 | leiomyoma cell line:10964C | 8.6 |
| CNhs12079 | Pericytes, donor2 | 8.5 |
| CNhs12201 | CD8+ T Cells (pluriselect), donor090325, donation1 | 8.3 |
| CNhs11717 | oral squamous cell carcinoma cell line:HSC-3 | 8.2 |
| CNhs12199 | CD8+ T Cells (pluriselect), donor090325, donation2 | 8.0 |
| CNhs14596 | Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2 | 7.9 |
| CNhs12659 | MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2 | 7.7 |
| CNhs12656 | MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2 | 7.6 |
| CNhs14533 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2 | 7.6 |
| CNhs14573 | Myoblast differentiation to myotubes, day06, control donor2 | 7.4 |
| CNhs12658 | MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2 | 7.3 |
| CNhs12317 | parietal lobe, adult, donor10252 | 7.3 |
| CNhs14488 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1 | 7.0 |
| CNhs12954 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2) | 6.9 |
| CNhs14591 | Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1 | 6.9 |
| CNhs12080 | Meningeal Cells, donor2 | 6.7 |
| CNhs12654 | MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2 | 6.5 |